ClinicalTrials.gg
Not yet recruitingNCT07829679Updated Sep 21, 2026

Development and Empirical Research on a Virtual Simulation Training System for Clinical Nurses Responding to Bioterrorist Attacks

An interventional study of Virtual simulation training on emergency response to bioterrorist attacks for nursing staff in Bioterrorism;Nurses;Computer Simulation;Biosafety Response Capability, sponsored by Air Force Military Medical University, China. Not yet recruiting. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Air Force Military Medical University, China · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

  • P (Population): Participants in a clinical nursing training program at a certain university
  • I (Intervention): Theoretical instruction + training using a self-developed virtual simulation platform for emergency response to bioterrorism incidents; intervention duration: 4 weeks
  • C (Comparison): Traditional in-person training (theoretical lectures + practical exercises)
  • O (Outcome): Assessment of nursing staff's biosafety response capabilities using the Clinical Nurse Biosafety Response Scale
Read the detailed description

This study aims to validate the effectiveness of a virtual simulation training system for emergency response to bioterrorism incidents in enhancing the biosafety response capabilities of clinical nursing staff. An asynchronous controlled trial was conducted, utilizing two consecutive training sessions for clinical nursing staff at a university; participants in the first session were assigned to the control group, while those in the second session were assigned to the intervention group. The control group received traditional in-person training (combining theoretical instruction with practical exercises), while the intervention group underwent training that combined theoretical instruction with the virtual simulation training platform developed for this study. The intervention duration was 4 weeks for both groups, and assessments were conducted before and after the intervention using the Clinical Nurse Biosafety Response Scale.

02

Conditions studied

  • Bioterrorism;Nurses;Computer Simulation;Biosafety Response Capability

Keywords

  • Computer Simulation;Bioterrorism;Emergency RespondersNurses;
03

In context

Lead sponsor

Air Force Military Medical University, China is the lead sponsor of 178 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (1) Possession of a valid nurse practicing license; (2) Clinical work experience of ≥ 1 year; (3) Provision of and voluntary participation in this study.

Exclusion criteria

Exclusion Criteria:

  • (1)Participants who withdrew from the study midway; (2)Those who had participated in similar emergency-rescue-related training recently (within the past 3 months).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Placebo comparator
    Conventional face-to-face training on emergency response to bioterrorist attacks

    The control group received \*\*conventional face-to-face training on emergency response to bioterrorist attacks\*\*, including theoretical lectures and practical drills.

    Other: Virtual simulation training on emergency response to bioterrorist attacks for nursing staff

  • Active comparator
    Virtual simulation training for emergency response to bioterrorist attacks

    The intervention group received theoretical lectures combined with \*\*virtual simulation training for emergency response to bioterrorist attacks\*\* developed in this study.

    Other: Virtual simulation training on emergency response to bioterrorist attacks for nursing staff

Interventions

  • OtherVirtual simulation training on emergency response to bioterrorist attacks for nursing staff

    This study focused on a training program for school nursing staff, with participants from the first cohort serving as the control group and those from the second cohort as the intervention group. A non-concurrent controlled experiment was conducted: the control group received traditional in-person training consisting of theoretical instruction and practical exercises, while the intervention group received training that combined theoretical instruction with a virtual simulation training platform developed for this study.

06

What researchers measure

Primary outcomes

  1. Biosafety incident response competence

    The training effect among nurses was evaluated using the self-developed biosecurity incident response competence scale of our research group, which covers four dimensions: biosecurity incident monitoring and early-warning competence, nursing management competence for biosecurity incidents, biosecurity knowledge readiness, and biosecurity infection-protection competence.

    Time frame: From enrollment to the completion of the four-week training.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2026
First posted
Sep 21, 2026
StartEst.
Oct 8, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07829679
Responsible party
Ning Zha (graduate student, Air Force Military Medical University, China) — Principal investigator
First posted
Sep 21, 2026
Start date
Oct 8, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Sep 21, 2026

Study contacts

Ning Zha Ning Zha, graduate degree
Contact
1241332783@qq.com
+84 17599456276

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion